Cardiac amyloidosis (CA), once considered a rare disease, is now being recognized more frequently by cardiologists. This is due in part to the improvement of diagnostic tools. Many patients with Transthyretin amyloid cardiomyopathy (ATTR-CM) travel long distances to a specialized center for the therapeutic interventions they need. This paper followed Doepker et al. (2023) specific formula for using google trends as a potential tool for predicting state demand. The Cardiologist Demand Index (CDI) for each state was developed. Based on the initial findings, states such as North Dakota, South Dakota, and Wyoming could benefit from opening Amyloidosis Treatment Centers in Academic Medical Centers. Amyloidosis Treatment Centers would benefit patients in these states due to the increase in public search inquiries (RSV data), access to clinical trials and research, and new treatments available to patients.
https://t.co/yIELPDkXJZ
A qualitative analysis of #CancerMoonshot finds ARPA-H emerged as the program’s central administrative priority. Read the analysis by Michael Turtz, Director of Administration at the Charles E. Schmidt College of Medicine. https://t.co/80ky94LyJS
A qualitative analysis of #CancerMoonshot finds ARPA-H emerged as the program’s central administrative priority. Read the analysis by Michael Turtz, Director of Administration at the Charles E. Schmidt College of Medicine. https://t.co/YnXCa1vfkS @MTurtz
A qualitative analysis of #CancerMoonshot finds Advanced Research Projects Agency for Health as the top priority. The article was written by Michael Turtz, at the Charles E. Schmidt College of Medicine and a PhD candidate. Read it here: https://t.co/M783W2OgIn
A qualitative analysis of #CancerMoonshot finds Advanced Research Projects Agency for Health as the top priority. The article was written by Michael Turtz, at the Charles E. Schmidt College of Medicine and a PhD candidate. Read it here: https://t.co/M783W2OgIn
IMPORTANT READING!
https://t.co/NDveoYJcN3
The objective of the paper is to highlight the growth of amyloidosis and amyloid related diseases policy in the United States federal government. The narrative review incorporated all the United States Government Records that mentioned amyloidosis from https://t.co/5beVWrZA39. There were four significant shifts in amyloidosis policy in the United States followed by a current state of stasis due to the restructuring of the NIH.
IMPORTANT READING!
https://t.co/NDveoYJcN3
The objective of the paper is to highlight the growth of amyloidosis and amyloid related diseases policy in the United States federal government. The narrative review incorporated all the United States Government Records that mentioned amyloidosis from https://t.co/5beVWrZA39. There were four significant shifts in amyloidosis policy in the United States followed by a current state of stasis due to the restructuring of the NIH.
I wrote about the public policy expansion of the TSA Screening Partnership Program in the Journal of Transportation Security @SpringerNature - https://t.co/9kPNVEvpKA
TSA is calling on private sector innovators to help make screening faster, smarter, and more secure.
Got a game-changing idea? Let's talk.
Visit here for more info: https://t.co/tmjqxt5trN
Now on #PATimes:
The Miami Formula One Grand Prix Successful Policy Process Through the Multiple-Streams Framework
By Michael Turtz
https://t.co/BZstyuefIQ